DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins (Q40561034)

21 September 2017

title

DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins (English)

1 reference

21 September 2017

Anthony P Wlazlo

1

1 reference

21 September 2017

Hongying Deng

series ordinal

2

1 reference

21 September 2017

Wynetta Giles-Davis

series ordinal

3

1 reference

21 September 2017

Hildegund C J Ertl

series ordinal

4

1 reference

21 September 2017

publication date

1 June 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

457-464

1 reference

Seroprevalence of human papillomavirus type 16 infection in the United States

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Human papillomavirus immortalization and transformation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

A modified DNA vaccine to p53 induces protective immunity to challenge with a chemically induced sarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

An experimental vaccine expressing wild-type p53 induces protective immunity against glioblastoma cells with high levels of endogenous p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

A method that allows easy characterization of tumor-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Cell interactions between histoincompatible T and B lymphocytes. IV. Involvement of the immune response (Ir) gene in the control of lymphocyte interactions in responses controlled by the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Enhanced tumour growth after DNA vaccination against human papilloma virus E7 oncoprotein: evidence for tumour-induced immune deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

7 January 2021

DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

7 January 2021

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700723

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700723

1 reference

Dimensions Publication ID

21 September 2017

1006112159

0 references

1 reference